Oligonucleotide Synthesis Market Global Trends, Market Share, Industry Size, Growth, Opportunities

The oligonucleotide synthesis market is anticipated to value over USD 4 billion by 2026 with a CAGR of over 12% during the forecast period 2019 to 2026.

Oligonucleotide synthesis is the process of compounding relatively short fragments of nucleic acid with a defined sequence. It is a vital part of genetic research and has a wide range of applications like diagnosis, tissue engineering, library preparation, DNA sequencing, PCR assays and so on. Due to such scope in the research and development, the oligonucleotide market is growing rapidly.

The inclination towards finding more efficient alternatives to traditional diagnostics and treatments is one of the factors driving the scale-up of the oligonucleotide synthesis market. For the past few years, several genetic diagnostic and clinical measures have boosted the market of oligonucleotide synthesis.

The oligonucleotide synthesizing equipment are expected to hold a large market share as they are the primary preference of end users. The key market players provide a range of synthesizers that add value to the market. Oligonucleotide synthesis is impossible without suitable reagents like linkers, activators, dyes, DNA probes and so on. This is a driving factor for the rise in demand of reagents in the market and is anticipated to hold a large share in the market.

Based on the applications, PCR primers and fluorescence in situ hybridization are anticipated to dominate the oligonucleotide synthesis market due to its wide use across the globe.

Currently, the pharmaceutical and biotechnological companies have their focus on the genetic sector for effective therapeutics and diagnostics. The investments by these companies in genetic research are growth factors for the oligonucleotide market.

North America region has its main focus on genetic research and development, it also possesses advanced technology as well as regulatory support for the study of genetic advancements. This factor dominates North America in the oligonucleotide synthesis market. Moreover, the Asia Pacific region has a good scope in the market due to inclination towards adopting genetic research.

The key market players are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare Dharmacon Inc., Agilent Technologies and so on. Thermo Fisher Scientific has a range of advanced genetic equipment with several applications like DNA sequencing, PCR, protein biology, etc. which are anticipated to be drivers for the market growth.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3379&page=requestsample

FutureWise Key Takeaways:

• Investment in genetic research
• Focus on advanced genetic synthesizers
• Collaborations with genetic research organizations

Global Oligonucleotide Synthesis Market Segmentation:

By Product:

• Oligonucleotides
• Equipment/ synthesizers
• Reagents
• Services

By Application:

• PCR primers
• PCR assays-panels
• Sequencing
• DNA microarrays
• Fluorescence in situ hybridization
• Antisense oligonucleotides
• Other applications

By End User:

• Pharmaceutical-biotechnology companies
• Diagnostic laboratories
• Academic research institutes

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3379&page=askfordiscount

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

Objectives of the Study:

• To provide with an exhaustive analysis on the oligonucleotide synthesis market by product, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

Table of Contents

Chapter 1 Executive Summary

1.1 Market Snapshot

Chapter 2 Research Methodology

2.1 Information procurement

2.1.1 Purchased database:

2.1.2 FutureWise's Internal Database

2.2 Information or Data Analysis

2.3 Market Formulation - Validation

2.4 Approaches for Market Estimation

2.4.1 Approach 1: Commodity flow - bottom up approach

2.4.2 Approach 2: Top down and parent market analysis

Chapter 3 Oligonucleotide Synthesis Market Variables, Trends - Scope

3.1 Market Segmentation - Scope

3.1.1 Market driver analysis

3.1.1.1 Strong pipeline of oligonucleotide therapeutics in clinical trials

3.1.1.2 Changing regulatory environments for genetic research and its applications in healthcare

3.1.1.3 High R - D spending of pharmaceutical - biotechnology companies

3.1.1.4 Increased public - private spending on genomics

3.1.1.5 Technological advancements in gene editing technologies

3.1.1.6 Exponentially declining cost of sequencing

3.1.1.7 Rising demand for synthetic genes

3.1.2 Market restraint analysis

3.1.2.1 Need for advanced oligo synthesis solutions

3.1.2.2 High cost associated with genomics research

3.1.2.3 Increasing wages of skilled employees in life science sector

3.1.2.4 Lack of skilled professionals and research support in undeveloped countries

3.2 Penetration - Growth Prospect Mapping for Application,

3.3 Oligonucleotide Synthesis -SWOT Analysis, By Factor (Political - Legal, Economic And Technological)

3.4 Industry Analysis - Porter’s

Chapter 4 Oligonucleotide Synthesis Market Categorization: Product Estimates - Trend Analysis

4.1 Global Oligonucleotide Synthesis Market: Product Movement Analysis, 2017 - 2025

4.2 Oligonucleotides

4.2.1 Global oligonucleotides market, 2014 - 2026 (USD Million)

4.2.2 Oligonucleotides, by product type

4.2.2.1 Column-based oligos

4.2.2.1.1 Global column-based oligos market, 2014 - 2026 (USD Million)

4.2.2.2 Array-based oligos

4.2.2.2.1 Global array-based oligos market, 2014 - 2026 (USD Million)

4.2.3 Oligonucleotides, by nucleic acid type

4.2.3.1 DNA oligos

4.2.3.1.1 Global DNA oligo market, 2014 - 2026 (USD Million)

4.2.3.2 RNA oligos

4.2.3.2.1 Global RNA oligo market, 2014 - 2026 (USD Million)

4.3 Equipment/ Synthesizers

4.3.1 Global oligonucleotide synthesis equipment market, 2014 - 2026 (USD Million)

4.4 Reagents

4.4.1 Global oligonucleotide synthesis reagents market, 2014 - 2026 (USD Million)

4.5 Services

4.5.1 Global oligonucleotide services market, 2014 - 2026 (USD Million)

4.5.2 Oligo synthesis

4.5.2.1 Global oligo synthesis services market, 2014 - 2026 (USD Million)

4.5.2.2 25 nmol

4.5.2.2.1 Global 25 nmol oligo synthesis services market, 2014 - 2026 (USD Million)

4.5.2.3 50 nmol

4.5.2.3.1 Global 50 nmol oligo synthesis services market, 2014 - 2026 (USD Million)

4.5.2.4 200 nmol

4.5.2.4.1 Global 200 nmol oligo synthesis services market, 2014 - 2026 (USD Million)

4.5.2.5 1,000 nmol

4.5.2.5.1 Global 1,000 nmol oligo synthesis services market, 2014 - 2026 (USD Million)

4.5.2.6 10,000 nmol

4.5.2.6.1 Global 10,000 nmol oligo synthesis services market, 2014 - 2026 (USD Million)

4.5.3 Purification

4.5.3.1 Global oligonucleotide purification services market, 2014 - 2026 (USD Million)

4.5.4 Modification

4.5.4.1 Global oligonucleotide modification services market, 2014 - 2026 (USD Million)

Chapter 5 Oligonucleotide Synthesis Market Categorization: Application Estimates - Trend Analysis

5.1 Global Oligonucleotide Synthesis Market: Application Movement Analysis, 2017 - 2025

5.2 PCR primers

5.2.1 Global PCR primer-based oligo synthesis market, 2014 - 2026 (USD Million)

5.3 PCR Assays - Panels

5.3.1 Global PCR assays - panels-based oligo synthesis market, 2014 - 2026 (USD Million)

5.4 Sequencing

5.4.1 Global sequencing-based oligo synthesis market, 2014 - 2026 (USD Million)

5.5 DNA Microarrays

5.5.1 Global DNA microarray-based oligonucleotide synthesis market, 2014 - 2026 (USD Million)

5.6 Fluorescence In Situ Hybridization (FISH)

5.6.1 Global FISH-based oligonucleotide synthesis market, 2014 - 2026 (USD Million)

5.7 Antisense Oligonucleotides

5.7.1 Global antisense oligonucleotide-based oligo synthesis market, 2014 - 2026 (USD Million)

5.8 Other Applications

5.8.1 Global other oligo synthesis applications market, 2014 - 2026 (USD Million)

Chapter 6 Oligonucleotide Synthesis Market Categorization: End Use Estimates - Trend Analysis

6.1 Global Oligonucleotide Synthesis Market: End Use Movement Analysis, 2017 - 2025

6.2 Pharmaceutical - Biotechnology Companies

6.2.1 Global pharmaceutical - biotechnology companies-based oligo synthesis market, 2014 - 2026 (USD Million)

6.3 Diagnostic Laboratories

6.3.1 Global diagnostic laboratories-based oligo synthesis market, 2014 - 2026 (USD Million)

6.4 Academic Research Institutes

6.4.1 Global academic research institutes-based oligo synthesis market, 2014 - 2026 (USD Million)

Chapter 7 Oligonucleotide Synthesis Market Categorization: Regional Estimates - Trend Analysis, by Product, Applications, - End Use

7.1 Oligonucleotide Synthesis Market Share By Region, 2016 - 2026

7.2 North America

7.2.1 North America oligonucleotide synthesis market, 2014 - 2026 (USD Million)

7.2.2 U.S.

7.2.2.1 U.S. oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.2.2.2 U.S. oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.2.2.3 U.S. oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.2.3 Canada

7.2.3.1 Canada oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.2.3.2 Canada oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.2.3.3 Canada oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.3 Europe

7.3.1 Europe oligonucleotide synthesis market, 2014 - 2026 (USD Million)

7.3.2 Germany

7.3.2.1 Germany oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.3.2.2 Germany oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.3.2.3 Germany oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.3.3 U.K.

7.3.3.1 U.K. oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.3.3.2 U.K. oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.3.3.3 U.K. oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.4 Asia Pacific

7.4.1 Asia Pacific oligonucleotide synthesis market, 2014 - 2026 (USD Million)

7.4.2 Japan

7.4.2.1 Japan oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.4.2.2 Japan oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.4.2.3 Japan oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.4.3 China

7.4.3.1 China oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.4.3.2 China oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.4.3.3 China oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.5 Latin America

7.5.1 Latin America oligonucleotide synthesis market, 2014 - 2026 (USD Million)

7.5.2 Brazil

7.5.2.1 Brazil oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.5.2.2 Brazil oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.5.2.3 Brazil oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

7.6 Middle East - Africa (MEA)

7.6.1 Middle East - Africa oligonucleotide synthesis market, 2014 - 2026 (USD Million)

7.6.2 South Africa

7.6.2.1 South Africa oligonucleotide synthesis market, by product 2014 - 2026 (USD Million)

7.6.2.2 South Africa oligonucleotide synthesis market, by application 2014 - 2026 (USD Million)

7.6.2.3 South Africa oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million)

Chapter 8 Competitive Landscape

8.1 Strategy Framework

8.2 Market Participation Categorization

8.3 List of Companies

8.4 Company Profiles

8.4.1 Thermo Fisher Scientific, Inc.

8.4.1.1 Company overview

8.4.1.1.1 Life Technologies Corporation

8.4.1.2 Financial performance

8.4.1.3 Product benchmarking

8.4.1.4 Strategic initiatives

8.4.2 Merck KGaA

8.4.2.1 Company overview

8.4.2.1.1 Sigma-Aldrich Co. LLC

8.4.2.1.2 Merck Millipore

8.4.2.2 Financial performance

8.4.2.2.1 Financial performance

8.4.2.3 Product Benchmarking

8.4.2.4 Strategic initiatives

8.4.3 GE Healthcare Dharmacon Inc.

8.4.3.1 Company overview

8.4.3.2 Financial performance

8.4.3.3 Product Benchmarking

8.4.3.4 Strategic Initiatives

8.4.4 Agilent Technologies

8.4.4.1 Company overview

8.4.4.2 Financial performance

8.4.4.3 Product Benchmarking

8.4.4.4 Strategic initiatives

8.4.5 Bio-synthesis

8.4.5.1 Company overview

8.4.5.2 Financial performance

8.4.5.3 Product benchmarking

8.4.5.4 Strategic initiatives

8.4.6 Kaneka Eurogentec S.A.

8.4.6.1 Company overview

8.4.6.2 Financial performance

8.4.6.3 Product benchmarking

8.4.6.4 Strategic initiatives

8.4.7 Integrated DNA Technologies, Inc.

8.4.7.1 Company overview

8.4.7.2 Financial performance

8.4.7.3 Product benchmarking

8.4.7.4 Strategic initiative

8.4.8 BioAutomation

8.4.8.1 Company overview

8.4.8.2 Financial performance

8.4.8.3 Product benchmarking

8.4.8.4 Strategic initiatives

8.4.9 LGC Biosearch Technologies

8.4.9.1 Company overview

8.4.9.2 Financial performance

8.4.9.3 Product benchmarking

8.4.9.4 Strategic initiatives

8.4.10 Biolegio B.V.

8.4.10.1 Company overview

8.4.10.2 Financial performance

8.4.10.3 Product benchmarking

8.4.10.4 Strategic initiatives

9 Research Finding and Conclusion

10 Appendix

10.1 Research Methodology

10.2 Research Data Source

Inquire further details about this report at: sales@futurewiseresearch.com

About FutureWise Research:

We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:

Company Name: FutureWise Research

Contact Person: Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 970 279 4295

City: Leeds

Country: United Kingdom

Website: www.futurewiseresearch.com

About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients.